Search research articles
Contact Us
Filters
Showing results (211-220 of 222) with videos related to
Page
of 23
Sort By:
Journal of Medicinal Chemistry
|
September 15, 2006
Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile
Yanping Xu, Garret J Etgen, Carol L Broderick, et al.
JAMA Network Open
|
July 8, 2025
Postoperative Delirium in Older Adults Undergoing Noncardiac Surgery
Heather L Lander, Andrew W Dick, Karen E Joynt Maddox, et al.
The American Journal of Psychiatry
|
September 1, 2025
The American Psychiatric Association Practice Guideline for the Prevention and Treatment of Delirium
Catherine Crone, Laura J Fochtmann, Iqbal Ahmed, et al.
Journal of the Academy of Consultation-Liaison Psychiatry
|
May 14, 2025
Catatonia: American Psychiatric Association Resource Document
Jo Ellen Wilson, Mark A Oldham, Andrew Francis, et al.
Journal of Medicinal Chemistry
|
June 19, 2001
Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists
D A Brooks, G J Etgen, C J Rito, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2007
Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists
Qing Shi, Emily J Canada, Yanping Xu, et al.
The Journal of Biological Chemistry
|
November 5, 2002
Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis
Guoqing Cao, Yu Liang, Carol L Broderick, et al.
Journal of Psychopharmacology (Oxford, England)
|
April 11, 2023
Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology
Jonathan P Rogers, Mark A Oldham, Gregory Fricchione, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2004
Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysis
Minmin Wang, Leonard L Winneroski, Robert J Ardecky, et al.
Diabetes
|
March 28, 2002
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models
Garret J Etgen, Brian A Oldham, William T Johnson, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 222) with videos related to
Sort By:
Page
of 23
Journal of Medicinal Chemistry
|
September 15, 2006
Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile
Yanping Xu, Garret J Etgen, Carol L Broderick, et al.
JAMA Network Open
|
July 8, 2025
Postoperative Delirium in Older Adults Undergoing Noncardiac Surgery
Heather L Lander, Andrew W Dick, Karen E Joynt Maddox, et al.
The American Journal of Psychiatry
|
September 1, 2025
The American Psychiatric Association Practice Guideline for the Prevention and Treatment of Delirium
Catherine Crone, Laura J Fochtmann, Iqbal Ahmed, et al.
Journal of the Academy of Consultation-Liaison Psychiatry
|
May 14, 2025
Catatonia: American Psychiatric Association Resource Document
Jo Ellen Wilson, Mark A Oldham, Andrew Francis, et al.
Journal of Medicinal Chemistry
|
June 19, 2001
Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists
D A Brooks, G J Etgen, C J Rito, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2007
Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists
Qing Shi, Emily J Canada, Yanping Xu, et al.
The Journal of Biological Chemistry
|
November 5, 2002
Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis
Guoqing Cao, Yu Liang, Carol L Broderick, et al.
Journal of Psychopharmacology (Oxford, England)
|
April 11, 2023
Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology
Jonathan P Rogers, Mark A Oldham, Gregory Fricchione, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2004
Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysis
Minmin Wang, Leonard L Winneroski, Robert J Ardecky, et al.
Diabetes
|
March 28, 2002
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models
Garret J Etgen, Brian A Oldham, William T Johnson, et al.
Page
of 23